Company
Product List
Offer to buy
Offer to sell
登入
加入會員
求助
Languages
English
繁體中文
簡體中文
Shanghai Tong Ren Pharmaceutical Co.,Ltd
回首頁
公司簡介
產品櫥窗
影音視聽
寄出詢問函
聯絡我們
Recommended Results
10% Ofloxacin Injection
產品分類 :
化學->化學用品進出口商->藥物
View Larger Picture
View Larger Picture
View Larger Picture
產品規格
Country
CN
Brand
cow-head
產品描述
PHYSICAL PROPERTY: Yellow clear liquid.
PHARMACOLOGY:
Ofloxacin is a broad spectrum fluoroquinolone antibacterial. It is active against most Gram-positive and Gram-negative bacteria, like E. Coli, Salmonella, Pseudomonas aeruginosa, Klebsiella, Proteus, Shigella, Staphylococci, Streptococci, Bacillus anthracis, Corynebacterium and etc. It is also active against most anaerobic bacteria, Mycobacteria, Mycoplasmas, Rickettsias, and the Protozoan Plasmodium falciparum.
Ofloxacin is bactericidal. The plasma concentrations for bactericidal and bacteriostatic effects are either the same or 2 to 4 times higher in bactericidal concentration. The antibacterial effect is not inhibited by the population of the pathogens or the presence of serum. However, urine with pH less than 5 or the increased level of Magnesium ions will adversely affect the antibacterial activities. There is no incompatibility with beta-lactam antibiotics and aminoglycosides.
(1) Ofloxacin can be inhibited by chemicals or feed additives with cations (Al3+\Mg2+\Ca2+\Fe2+\Zn2+). It may result in lower plasma concentration and thus leading to reduced antibacterial activities.
(2) Ofloxacin will also decrease the clearance of Theophylline and Caffeine and this will increase the serum level of the 2 chemicals.
(3) Rifampicin, Chloramphenicol, Thiamphenicol and Florfenicol may have antagonistic effects with Ofloxacin.
(4) Probenecid will reduce the urinary secretion of Ofloxacin. The plasma concentration is not necessarily increased.
INDICATIONS:
As a broad spectrum antibacterial and is used mainly for bacterial as well as mycobacterial infections in animals. It is especially indicated for use in treating respiratory diseases, gastro-intestinal and urinary-tract infections.
ADMINISTARTION AND DOSAGE:
Administer via intra-muscular or intravenous injection. Dosage: 0.03ml to 0.05ml per kg body weight or 0.3ml to 0.5ml per 10kg body weight and twice a day. Treat 3 to 5 days.
ADVERSE EFFECTS:
Prolonged usage or overdose could cause the following adverse effects:
1. Reversible arthralgia as well as joint erosions in immature animals.
2. Central Nervous System Toxicity: Epileptic convulsions, acute psychosis and extreme irritability in small animals.
3. For animals with impaired renal function, there is a risk to develop crystalluria.
PRECAUTIONS:
1. Prohibited for use for puppies under 8 weeks of age as well as lactating or pregnant animals
2. Special cautionary measures for treating young breeders, horses, animals for meat consumption and animals with impaired renal function.
WITHDRAWAL:
28 days, Milk for human consumption: 7 days. Not for use in hens laying eggs for human consumption.
STANDARD: 10ml: 1g; 50ml: 5g; 100ml: 10g
PACKING: 5 ampoules× 10ml; 50ml/vial; 100ml/vial
STORAGE: Store in sealed containers and keep form lig
其他類似產品
10% Gentamycin Sulfate Injection
Oxytetracycline 20% Long-acting Injection
Amisyn 10% (Amikacin Sulfate 10% Injection)
Nikang (Florfenicol 30% Injection)
[ Back Products Catalog ]
Commerce 會員:
請登入您的 帳號 跟 密碼, 系統將自動為您填入您的相關基本資料!
帳號:
密碼:
記住我的帳號
填寫下列表格並寄送詢問函.所有的詢問信函將會自動寄發給你想聯絡的公司
主旨
內容
﹙ 請勿輸入公司名稱、Email、電話、傳真、網址 ﹚
公司簡介:
*
公司名稱
*
E-mail
*
國家
Please Select Your Country
United States
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaidjan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
Former Czechoslovakia
Former USSR
France
France (European Territory)
French Guyana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Great Britain
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guinea
Guinea Bissau
Guyana
Haiti
Heard and McDonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldavia
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
Neutral Zone
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion (French)
Romania
Russian Federation
Rwanda
S. Georgia & S. Sandwich Isls.
Saint Helena
Saint Kitts & Nevis Anguilla
Saint Lucia
Saint Pierre and Miquelon
Saint Tome (Sao Tome) and Principe
Saint Vincent & Grenadines
Samoa
San Marino
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovak Republic
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Tajikistan
Taiwan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vanuatu
Vatican City State
Venezuela
Vietnam
Virgin Islands (British)
Virgin Islands (USA)
Wallis and Futuna Islands
Western Sahara
Yemen
Yugoslavia
Zaire
Zambia
Zimbabwe
*
聯絡人
網址
*
電話
-
-
傳真
-
-
*
郵遞區號
*
城市
*
街道地址
*
企業形態
批發商
出口商
進口商
製造商
大盤商
零售商
代理商
Retrofitter
使用者
其他, 請詳細說明:
*
安全密碼
請輸入所顯示的安全密碼
網站導覽 l
隱私權政策 l
服務團隊 l
合作提案 l
聯絡我們 l
幫幫我 l
廣告刊登 l
B2B商業夥伴
.